Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 4Stomatitis 3Neoplasm Metastasis 2Head and Neck Neoplasms 2Cancer Pain 2Thromboembolism 1Successful Conversion Rate of Operation 1Sarcoma 1Respiratory Insufficiency 1Prostatic Neoplasms 1Pneumonia 1Pancreatic Neoplasms 1Pain 1Myocardial Infarction 1Multiple Myeloma 1Mucositis 1Lymphoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Kidney Diseases 1Hematologic Neoplasms 1Arrhythmias, Cardiac 1Angina, Unstable 1Adenocarcinoma 1Acute Coronary Syndrome 1

Interventions

Sunitinib 3avelumab 2Nutrition Assessment 2Axitinib 2trifluridine tipiracil drug combination 1trebananib 1spartalizumab 1pembrolizumab 1palbociclib 1etelcalcetide hydrochloride 1enzalutamide 1cabozantinib 1bicalutamide 1atezolizumab 1aldesleukin 1Valsartan 1VMBP protocol 1Stents 1Sorafenib 1Sodium Bicarbonate 1Resistance Training 1Receptors, Androgen 1Plasma Exchange 1Pharmaceutical Preparations 1Paclitaxel 1Oxaliplatin 1Nivolumab 1Nephrotomy 1Nephrostomy, Percutaneous 1Lysine Acetyltransferase 5 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Kidney Diseases × Sodium Bicarbonate × Clear all
NCT00540904 2014-03-03

Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate

Barretos Cancer Hospital

Phase 2 Completed
27 enrolled
Genitourinary

Kidney Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡